The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1617
ISSUE1617
February 8, 2021
Twirla - A New Contraceptive Patch
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Twirla - A New Contraceptive Patch
February 8, 2021 (Issue: 1617)
The FDA has approved Twirla (Agile Therapeutics),
a transdermal contraceptive patch containing the
estrogen ethinyl estradiol and the progestin
levonorgestrel, for use in women with a BMI...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.